Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Halaban

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Pigment Cell & Melanoma Research|February 13, 2010
PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cellsRuth Halaban, Wengeng Zhang, Antonella Bacchiocchi, et al.
Molecular Cancer Research : MCR|April 28, 2011
Phosphoproteomic screen identifies potential therapeutic targets in melanomaKathryn Tworkoski, Garima Singhal, Sebastian Szpakowski, et al.
Genome Research|June 4, 2009
Genome-wide screen of promoter methylation identifies novel markers in melanomaYasuo Koga, Mattia Pelizzola, Elaine Cheng, et al.
The Yale Journal of Biology and Medicine|September 27, 2012
Integrated analysis of tumor samples sheds light on tumor heterogeneityFabio Parisi, Mariann Micsinai, Francesco Strino, et al.
Cell Reports|September 19, 2023
Unannotated microprotein EMBOW regulates the interactome and chromatin and mitotic functions of WDR5Yanran Chen, Haomiao Su, Jianing Zhao, et al.
Immunological Reviews|July 26, 2023
CD4 T cells and toxicity from immune checkpoint blockadeNoah Earland, Wubing Zhang, Abul Usmani, et al.
Science (New York, N.Y.)|February 21, 2015
Photochemistry. Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposureSanjay Premi, Silvia Wallisch, Camila M Mano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2014
Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivoRituparna Das, Rakesh Verma, Mario Sznol, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2008
Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesionsBonnie E Gould Rothberg, Christopher B Moeder, Harriet Kluger, et al.
Oncotarget|July 19, 2024
Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanomaCaroline Naomi Valdez, Gabriela Athziri Sánchez-Zuno, Lais Osmani, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Pigment Cell & Melanoma Research|February 13, 2010
PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cellsRuth Halaban, Wengeng Zhang, Antonella Bacchiocchi, et al.
Molecular Cancer Research : MCR|April 28, 2011
Phosphoproteomic screen identifies potential therapeutic targets in melanomaKathryn Tworkoski, Garima Singhal, Sebastian Szpakowski, et al.
Genome Research|June 4, 2009
Genome-wide screen of promoter methylation identifies novel markers in melanomaYasuo Koga, Mattia Pelizzola, Elaine Cheng, et al.
The Yale Journal of Biology and Medicine|September 27, 2012
Integrated analysis of tumor samples sheds light on tumor heterogeneityFabio Parisi, Mariann Micsinai, Francesco Strino, et al.
Cell Reports|September 19, 2023
Unannotated microprotein EMBOW regulates the interactome and chromatin and mitotic functions of WDR5Yanran Chen, Haomiao Su, Jianing Zhao, et al.
Immunological Reviews|July 26, 2023
CD4 T cells and toxicity from immune checkpoint blockadeNoah Earland, Wubing Zhang, Abul Usmani, et al.
Science (New York, N.Y.)|February 21, 2015
Photochemistry. Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposureSanjay Premi, Silvia Wallisch, Camila M Mano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2014
Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivoRituparna Das, Rakesh Verma, Mario Sznol, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2008
Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesionsBonnie E Gould Rothberg, Christopher B Moeder, Harriet Kluger, et al.
Oncotarget|July 19, 2024
Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanomaCaroline Naomi Valdez, Gabriela Athziri Sánchez-Zuno, Lais Osmani, et al.
Pageof 9